{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:30:07Z","timestamp":1789914607867,"version":"4.0.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.15252\/emmm.201809369","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T09:05:47Z","timestamp":1532336747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Microglia P2X4 receptors as pharmacological targets for demyelinating diseases"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3566-1362","authenticated-orcid":false,"given":"Francesco","family":"Di Virgilio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba Clara","family":"Sarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"key":"BFEMMM201809369_CR1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15: 545\u2013558","journal-title":"Nat Rev Immunol"},{"key":"BFEMMM201809369_CR2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tins.2008.11.003","volume":"32","author":"F Di Virgilio","year":"2009","unstructured":"Di Virgilio F, Ceruti S, Bramanti P, Abbracchio MP (2009) Purinergic signalling in inflammation of the central nervous system. Trends Neurosci 32: 79\u201387","journal-title":"Trends Neurosci"},{"key":"BFEMMM201809369_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S (2017) The P2X7 receptor in infection and inflammation. Immunity 47: 15\u201331","journal-title":"Immunity"},{"key":"BFEMMM201809369_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1085\/jgp.201711870","volume":"150","author":"G Fois","year":"2018","unstructured":"Fois G, Winkelmann VE, Bareis L, Staudenmaier L, Hecht E, Ziller C, Ehinger K, Schymeinsky J, Kranz C, Frick M (2018) ATP is stored in lamellar bodies to activate vesicular P2X4 in an autocrine fashion upon exocytosis. J Gen Physiol 150: 277\u2013291","journal-title":"J Gen Physiol"},{"key":"BFEMMM201809369_CR5","doi-asserted-by":"crossref","first-page":"17658","DOI":"10.1074\/jbc.M114.552158","volume":"289","author":"P Huang","year":"2014","unstructured":"Huang P, Zou Y, Zhong XZ, Cao Q, Zhao K, Zhu MX, Murrell\u2010Lagnado R, Dong XP (2014) P2X4 forms functional ATP\u2010activated cation channels on lysosomal membranes regulated by luminal pH. J Biol Chem 289: 17658\u201317667","journal-title":"J Biol Chem"},{"key":"BFEMMM201809369_CR6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrn.2018.2","volume":"19","author":"K Inoue","year":"2018","unstructured":"Inoue K, Tsuda M (2018) Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential. Nat Rev Neurosci 19: 138\u2013152","journal-title":"Nat Rev Neurosci"},{"key":"BFEMMM201809369_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","volume":"91","author":"H Kettenmann","year":"2011","unstructured":"Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91: 461\u2013553","journal-title":"Physiol Rev"},{"key":"BFEMMM201809369_CR8","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1523\/JNEUROSCI.19-17-07289.1999","volume":"19","author":"BS Khakh","year":"1999","unstructured":"Khakh BS, Proctor WR, Dunwiddie TV, Labarca C, Lester HA (1999) Allosteric control of gating and kinetics at P2X(4) receptor channels. J Neurosci 19: 7289\u20137299","journal-title":"J Neurosci"},{"key":"BFEMMM201809369_CR9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","volume":"16","author":"VE Miron","year":"2013","unstructured":"Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin RJM et\u00a0al (2013) M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16: 1211\u20131218","journal-title":"Nat Neurosci"},{"key":"BFEMMM201809369_CR10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1085\/jgp.201711963","volume":"150","author":"RD Murrell\u2010Lagnado","year":"2018","unstructured":"Murrell\u2010Lagnado RD (2018) A role for P2X4 receptors in lysosome function. J Gen Physiol 150: 185\u2013187","journal-title":"J Gen Physiol"},{"key":"BFEMMM201809369_CR11","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1038\/emboj.2010.126","volume":"29","author":"L Ulmann","year":"2010","unstructured":"Ulmann L, Hirbec H, Rassendren F (2010) P2X4 receptors mediate PGE2 release by tissue\u2010resident macrophages and initiate inflammatory pain. EMBO J 29: 2290\u20132300","journal-title":"EMBO J"},{"key":"BFEMMM201809369_CR12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","volume":"79","author":"SA Wolf","year":"2017","unstructured":"Wolf SA, Boddeke HW, Kettenmann H (2017) Microglia in physiology and disease. Annu Rev Physiol 79: 619\u2013643","journal-title":"Annu Rev Physiol"},{"key":"BFEMMM201809369_CR13","doi-asserted-by":"crossref","first-page":"e8743","DOI":"10.15252\/emmm.201708743","volume":"10","author":"A Zabala","year":"2018","unstructured":"Zabala A, Vazquez\u2010Villoldo N, Rissiek B, Gejo J, Martin A, Palomino A, Samartin\u2010Perez A, Pulagam KR, Lukowiak M, Capetillo\u2010Zarate E et\u00a0al (2018) P2X4 receptor controls microglia activation and favours remyelination in autoimmune encephalitis. EMBO Mol Med 10: e8743","journal-title":"EMBO Mol Med"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201809369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201809369","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201809369\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201809369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201809369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:28:14Z","timestamp":1779085694000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201809369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8,1]]}},"alternative-id":["BFEMMM201809369"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201809369","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,23]]},"assertion":[{"value":"23 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FDV is a member of the Scientific Advisory Board of Biosceptre Ltd, a UK\u2010based biotech company involved in the development of P2X7R\u2010targeted therapeutics. ACS declares no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"EMMM201809369"}}